Log in | Register

Health Canada Informs Canadians of Pfizer’s Recommendations on the Correct Use of EpiPen and EpiPen Jr. Auto-Injector

For the latest pharmaceutical news and updates - Sign up now!
Loading...

OTTAWA - Health Canada is informing Canadians of Pfizer Canada's instruction for the correct use of EpiPen and EpiPen Jr., particularly the correct way to remove the blue safety caps. According to the company, it is important that the blue safety cap be removed by pulling the cap straight up while the device is held with the orange tip pointing downward. Pfizer states that inappropriate removal of the blue safety cap may prevent the device from working properly and potentially result in failure to deliver the drug.

Pfizer instructs that the blue safety cap should not be removed by pulling it sideways or bending and twisting it off and that the blue safety cap should not be removed until you need to use the EpiPen or EpiPen Jr.

EpiPen (0.3 mg epinephrine auto-injector) and EpiPen Jr (0.15 mg epinephrine auto-injector) are pre-filled, single-use auto-injectors containing an epinephrine solution that is used for the emergency treatment of severe allergic reactions, including anaphylaxis.

Pfizer recommends that consumers should continue to carry their EpiPen or EpiPen Jr. at all times, regularly review the instructions for how to use their product and check that it has not been unintentionally activated.

Health Canada recommends that consumers should consult with their healthcare practitioner with any questions or concerns regarding the use of their EpiPen or EpiPen Jr. Consumers may also contact the company directly at 1-800-463-6001 or check Next link will take you to another Web site the website for more information.

Canadians can be confident that Health Canada is working with Pfizer to inform Canadians and their health care practitioners regarding Pfizer's instructions for the safe use of these products. Should additional information be identified, Health Canada will take appropriate action and inform Canadians.

Any malfunction or serious or unexpected adverse reactions in patients receiving EpiPen or EpiPen Jr. should be reported to Health Canada and Pfizer Canada Inc. To report suspected adverse events to these or other health products, please contact the Canada Vigilance Program of Health Canada toll-free at 1-866-234-2345, or complete a Canada Vigilance Reporting Form and send to us using one of these methods:

  • Fax: 1-866-678-6789
  • Internet: MedEffect Canada
  • Mail: Canada Vigilance Program
    Marketed Health Products Directorate
    Ottawa, ON, Address Locator 0701E
    K1A 0K9

Complaints involving health products can be reported to the Health Products and Food Branch Inspectorate by calling the toll-free hotline at 1-800-267-9675, or by writing to:

Health Products and Food Branch Inspectorate
Health Canada
Address Locator: 2003D
Ottawa, Ontario K1A 0K9

-30-


Media Enquiries:
Health Canada
(613) 957-2983

Public Enquiries:
(613) 957-2991
1-866 225-0709

SOURCE

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Measles Infections on the Rise in the U.S.

Measles Infections on the Rise in the U.S.

Apr 20 | Video

Just over a decade ago, U.S. health officials believed measles would be eradicated, but according to a new report from the Centers for Disease Control, infections are back and the numbers are growing. Dr. Nancy Snyderman, NBC's Chief Medical Editor reports.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter